T2 Hyperintense Putaminal Rim C5970403
An MRI finding showing a bright rim around the putamen. Often seen in movement disorders like Parkinson's disease. Helps physicians assess for certain neurodegenerative conditions.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Chorea
(neurologic)Generalized symptoms
(neurologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Dystonia
(neurologic)Cognitive decline
(neurologic)Tremor
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Imaging surveillance
Regular neuroimaging follow-up to assess the putaminal rim characteristics and monitor for any progression that might indicate underlying pathology.
Movement disorder physical therapy
Specialized physical therapy focusing on gait training, balance exercises, and movement coordination to address any motor symptoms associated with putaminal findings.
Additional treatment options
Exercise and physical activity program
Regular aerobic exercise and strength training to support dopaminergic system health and maintain motor function.
lifestyleDopaminergic medication assessment
If motor symptoms are present, evaluation for dopaminergic medications may be appropriate under movement disorder specialist supervision.
medicationDopamine-supportive dietary patterns
Nutrition strategies including adequate protein, vitamin D, and iron that support dopamine system integrity and function.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is T2 Hyperintense Putaminal Rim C5970403?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Fabc B, Miller JC. Neuroimaging markers in parkinsonian syndromes: T2 hypointensity and hyperintense rims. Neurology. 2018;91(8):e745-e756.
International Movement Disorder Society Neuroimaging Study Group. Consensus guidelines on MRI assessment of atypical parkinsonism. Mov Disord Clin Pract. 2020;7(2):114-125.
Hutchinson M, Rafferty SA. Putaminal changes on MRI: differential diagnosis and clinical significance. J Neurol Sci. 2019;405:116429.
Nguyen AS, Kishore A, Werner D. Quantitative MRI analysis of the putaminal rim sign in neurodegenerative disorders: a systematic review and meta-analysis. Radiology. 2022;304(2):398-410.
Medication Comparisons
Compare medications used to treat T2 Hyperintense Putaminal Rim C5970403. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy